Other Presentations
Switch To Module
  • Poster Presentations
  • Other Presentations
  • Person Lookup
Everything
  • Everything
  • Session Title
  • Session Number
  • Title
  • Presentation Number
  • Author
  • Presenter
Filter By
Day
Presentation Type
Presentation Topic
  • BSTR
  • CASE
  • HF
  • HTX
  • ID
  • LTX
  • MCS
  • NHSAH
  • PEDS
  • PH
  • PHARM
Advanced Search
  • Poster Presentations
  • Other Presentations:
  • Featured
  • Orals
  • Mini Orals

491 - Gene Expression Profiling in Murine Orthotopic Lung Transplantation Model of Chronic Lung Allograft Dysfunction (CLAD)

Oral BSTR - Immunology, Inflammation, Immunosuppression

491 - Gene Expression Profiling in Murine Orthotopic Lung Transplantation Model of Chronic Lung Allograft Dysfunction (CLAD)

Presentation Number
491
Presenter
  • A. Hata, Chiba, Japan
Co-Authors
  • M. Chiyo, Chiba, Japan
  • T. Fujiwara, Chiba, Japan
  • A. Hata, Chiba, Japan
  • T. Kaiho, Chiba, Japan
  • T. Nakajima, Chiba, Japan
  • K. Nishii, Chiba, Japan
  • H. Oeda, Chiba, Japan
  • K. Ohashi, Chiba, Japan
  • Y. Sakairi, Chiba, Japan
  • Y. Sata, Chiba, Japan
  • Y. Shiina, Chiba, Japan
  • H. Suzuki, Chiba, Japan
  • H. Tamura, Chiba, Japan
  • T. Toyoda, Chiba, Japan
  • H. Wada, Chiba, Japan
  • Y. Yamada, Chiba, Japan
  • I. Yoshino, Chiba, Japan
Previous Poster Next Poster

Previous Eposter

22 - Clinical Outcomes Associated With mTORi Initiation in Adult Heart Transplant: An ISHLT Registry Analysis

Next Eposters

291 - Inhibition of Neutrophil Serine Proteases by Alpha 1 Antitrypsin During Storage Preserves Primary Graft Functions of Transplanted Murine Donor Lungs
442 - Human Leukocyte Compatibility and Heart Transplant Survival Using a Validated Matching Algorithm
314 - The ISHLT 2017 Updated DCD Registry Report
376 - Defining Severe Secondary Antibody Deficiency in Heart and Lung Transplantation
97 - Extracorporeal Membrane Oxygenation for Cardiogenic Shock: National trends in the United States 2008-2012
412 - Survival and Graft Function in Heart Transplant Patients Receiving Adverse Risk Profile Donor Hearts
454 - NT-proBNP Levels Are Reduced Following Treatment With Growth Hormone in Chronic Heart Failure Due to Ischemic Heart Disease. A Randomized Double Blind Placebo Controlled Trial
31 - Mitochondrial Transplantation Prolongs Cold Preservation Time in Murine Cardiac Transplantation
282 - Frailty Assessment in Lung Transplant Candidates: The Use of the Short Performance Physical Battery
476 - Transplant Outcomes of Adult Donor Hearts with Prior Quality-based Offer Refusals

Questions about ePosters? Contact CTI Meeting Technologies Technical Support at ishlt@support.ctimeetingtech.com or 217-398-1792.

Questions about the "ISHLT 38th Annual Meeting and Scientific Sessions"? Contact  communications@ishlt.org.

 CTI Meeting Technologies© All Rights Reserved.